Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...

Growth stocks are in focus as President Donald Trump’s tariffs on Mexico and Canada went live on Tuesday, March 4. His ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...

Nvidia ( NASDAQ: NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes ...

Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, Big Tech, and stock market trends in 2025. He also dives into AI’s ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Wedbush in a ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to ...